FDA Approved: AZACITIDINE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for azacitidine from BluePoint Laboratories, indicating an update to the drug's labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

SUPPL AP for AZACITIDINE (AZACITIDINE)